PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy

被引：0
|
作者：
Lidija Antunovic
Rita De Sanctis
Luca Cozzi
Margarita Kirienko
Andrea Sagona
Rosalba Torrisi
Corrado Tinterri
Armando Santoro
Arturo Chiti
Renata Zelic
Martina Sollini
机构：
[1] Humanitas Clinical and Research Center- IRCCS,Department of Nuclear Medicine
[2] Humanitas Clinical and Research Center- IRCCS,Department of Medical Oncology and Hematology
[3] Humanitas University,Department of Biomedical Sciences
[4] Humanitas Clinical and Research Center- IRCCS,Breast Surgery Department
[5] Karolinska Institutet,Clinical Epidemiology Unit, Department of Medicine Solna
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
Breast cancer; Neoadjuvant chemotherapy; Radiomics; Advanced features; F-FDG PET/CT; Treatment response prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1468 / 1477
页数：9
相关论文
共 50 条
  • [31] Breast MRI radiomics for the pretreatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients
    Drukker, Karen
    Edwards, Alexandra
    Doyle, Christopher
    Papaioannou, John
    Kulkarni, Kirti
    Giger, Maryellen L.
    JOURNAL OF MEDICAL IMAGING, 2019, 6 (03)
  • [32] Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy
    Bas B. Koolen
    Kenneth E. Pengel
    Jelle Wesseling
    Wouter V. Vogel
    Marie-Jeanne T. F. D. Vrancken Peeters
    Andrew D. Vincent
    Kenneth G. A. Gilhuijs
    Sjoerd Rodenhuis
    Emiel J. Th. Rutgers
    Renato A. Valdés Olmos
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 32 - 40
  • [33] Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
    R. S. Gillies
    M. R. Middleton
    C. Blesing
    K. Patel
    N. Warner
    R. E. K. Marshall
    N. D. Maynard
    K. M. Bradley
    F. V. Gleeson
    European Radiology, 2012, 22 : 2035 - 2043
  • [34] Prediction of pathological response after neoadjuvant chemotherapy using baseline FDG PET heterogeneity features in breast cancer
    Oliveira, Carla
    Oliveira, Francisco
    Vaz, Sofia C.
    Marques, Hugo Pinto
    Cardoso, Fatima
    BRITISH JOURNAL OF RADIOLOGY, 2023, 96 (1146)
  • [35] Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
    Braman, Nathaniel M.
    Etesami, Maryam
    Prasanna, Prateek
    Dubchuk, Christina
    Gilmore, Hannah
    Tiwari, Pallavi
    Pletcha, Donna
    Madabhushi, Anant
    BREAST CANCER RESEARCH, 2017, 19
  • [36] Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
    Nathaniel M. Braman
    Maryam Etesami
    Prateek Prasanna
    Christina Dubchuk
    Hannah Gilmore
    Pallavi Tiwari
    Donna Plecha
    Anant Madabhushi
    Breast Cancer Research, 19
  • [37] Ensemble Methods with [18F]FDG-PET/CT Radiomics in Breast Cancer Response Prediction
    Dholey, Moumita
    Santosham, Ritesh J. M.
    Ray, Soumendranath
    Das, Jayanta
    Chatterjee, Sanjoy
    Ahmed, Rosina
    Mukherjee, Jayanta
    PATTERN RECOGNITION AND MACHINE INTELLIGENCE, PREMI 2023, 2023, 14301 : 369 - 379
  • [38] Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
    Gillies, R. S.
    Middleton, M. R.
    Blesing, C.
    Patel, K.
    Warner, N.
    Marshall, R. E. K.
    Maynard, N. D.
    Bradley, K. M.
    Gleeson, F. V.
    EUROPEAN RADIOLOGY, 2012, 22 (09) : 2035 - 2043
  • [39] MRI and RNA-seq fusion for prediction of pathological response to neoadjuvant chemotherapy in breast cancer
    Li, Hui
    Zhao, Yuanshen
    Duan, Jingxian
    Gu, Jia
    Liu, Zaiyi
    Zhang, Huailing
    Zhang, Yuqin
    Li, Zhi-Cheng
    DISPLAYS, 2024, 83
  • [40] Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
    Andrade, W. P.
    Lima, E. N. P.
    Osorio, C. A. B. T.
    do Socorro Maciel, M.
    Baiocchi, G.
    Bitencourt, A. G. V.
    Fanelli, M. F.
    Damascena, A. S.
    Soares, F. A.
    EJSO, 2013, 39 (12): : 1358 - 1363
12345